Get the full experience! Sign up to access transcripts, personalized summaries, and more features.
Could Intel exit the high-end chip game entirely? Why are public companies loading up on crypto? GPT-5 is probably coming in a matter of weeks. What if it’s actually AI jobpocalypse… not now? And in the Longreads, the best explainer of those GLP-1 drugs I’ve read so far.
Links:
Weekend Longreads Suggestions:
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
On July 25th, Intel reported earnings that were stable but underscored significant restructuring efforts. CEO LipBoo Tan indicated a cautious approach toward new investments, mentioning the cancellation of planned fabs in Europe and a reevaluation of operations based on confirmed customer needs. Increased layoffs are anticipated, with Intel's workforce projected to shrink by 15% by the end of 2025, raising concerns over its future in advanced chip manufacturing.
Google is testing a coding tool named Opal, which allows users to create web apps using simple text prompts. This reflects a broader trend where major tech companies are developing AI-powered tools for easier app creation, catering to non-technical users through a more visual interface.
There's a rising trend of public companies investing in cryptocurrencies beyond Bitcoin, with attempts to leverage these assets to boost share prices. The Financial Times highlights various firms joining this trend, including the strategic acquisition of tokens associated with popular platforms like Telegram.
OpenAI's upcoming GPT-5 model is set to be released soon, with early indications suggesting groundbreaking capabilities. This launch aims to integrate various AI technologies and could be instrumental in shaping future developments within the field.
The job market is experiencing significant changes, particularly within entry-level roles, which have decreased markedly since 2022. Analysis suggests that while AI is part of the disruption narrative, economic fluctuations and offshoring play crucial roles in altering the employment landscape.
Explorations surrounding GLP-1 drugs suggest they may offer beyond weight loss, with potential benefits impacting various health issues, including diabetes management and even neurodegenerative diseases. New studies indicate a broad spectrum of health improvements linked to these drugs.
Join other podcast enthusiasts who are getting podcast summaries.
Sign Up Free